Pharma solutions

We strive to address unmet medical needs through excellence in science

At Roche Pharmaceuticals, we focus on finding new medicines that help patients live longer, better lives and evolve the practice of medicine.

Actemra®

(tocilizumab)

Alecensa®

(alectinib)

Avastin®

(bevacizumab)

Casirivimab and Imdevimab

Cellcept®

(mycophenolate mofetil)

Columvi®

(glofitamab)

Copegus®

(ribavirin)

Cotellic®

(cobimetinib)

Enspryng®

(satralizumab)

Esbriet®

(pirfenidone)

Evrysdi®

(risdiplam)

Gazyva®

(obinutuzumab)

Hemlibra®

(emicizumab)

Herceptin®

(trastuzumab)

Kadcyla®

(trastuzumab emtansine)

Lunsumio®

(mosunetuzumab)

MabThera®

(rituximab)

Madopar®

(levodopa + benserazide)

Mircera®

(methoxy polyethylene glycol-epoetin beta)

Ocrevus®

(ocrelizumab)

Perjeta®

(pertuzumab)

Phesgo®

(pertuzumab and trastuzumab)

Polivy®

(polatuzumab vedotin)

Recormon®

(epoetin beta)

Roaccutane®

(isotretinoin)

Rocephin®

(ceftriaxone)

Rozlytrek®

(entrectinib)

Tamiflu®

(oseltamivir)

Tarceva®

(erlotinib)

Tecentriq®

(atezolizumab)

Vabysmo®

(faricimab)

Xofluza®

(baloxavir marboxil)

Zelboraf®

(vemurafenib)

Mircera®

(methoxy polyethylene glycol-epoetin beta)

Recormon®

(epoetin beta)

Casirivimab and Imdevimab

Columvi®

(glofitamab)

Copegus®

(ribavirin)

Tamiflu®

(oseltamivir)

Xofluza®

(baloxavir marboxil)

Actemra®

(tocilizumab)

MabThera®

(rituximab)

Enspryng®

(satralizumab)

Evrysdi®

(risdiplam)

Madopar®

(levodopa + benserazide)

Roaccutane®

(isotretinoin)

Esbriet®

(pirfenidone)

Hemlibra®

(emicizumab)

Rocephin®

(ceftriaxone)

Xofluza®

(baloxavir marboxil)

Alecensa®

(alectinib)

Avastin®

(bevacizumab)

Cotellic®

(cobimetinib)

Gazyva®

(obinutuzumab)

Herceptin®

(trastuzumab)

Kadcyla®

(trastuzumab emtansine)

MabThera®

(rituximab)

Perjeta®

(pertuzumab)

Phesgo®

(pertuzumab and trastuzumab)

Polivy®

(polatuzumab vedotin)

Rozlytrek®

(entrectinib)

Tarceva®

(erlotinib)

Tecentriq®

(atezolizumab)

Xeloda®

(capecitabine)

Zelboraf®

(vemurafenib)

Vabysmo®

(faricimab)

Cellcept®

(mycophenolate mofetil)